The role of airways 17ß-estradiol as a biomarker of severity in post-menopausal asthma Source: Virtual Congress 2020 – Respiratory homeostasis and structural changes in disease Year: 2020
The role of biomarkers in the management of severe asthma Source: International Congress 2019 – Severe asthma guidelines: update 2019 Year: 2019
Upregulation of interleukin-19 in severe asthma: a potential saliva biomarker for asthma severity Source: ERJ Open Res, 7 (3) 00984-2020; 10.1183/23120541.00984-2020 Year: 2021
Effect of BMI on asthma control, asthma severity and quality of life in adult patients with asthma Source: Annual Congress 2011 - Asthma: improving diagnosis and management for reaching better control Year: 2011
Can asthma severity be a predictor of exacerbation severity? Source: Eur Respir J 2003; 22: Suppl. 45, 371s Year: 2003
The influence of atopy on asthma severity in children Source: Eur Respir J 2001; 18: Suppl. 33, 454s Year: 2001
Asthma in combination with rhinitis and eczema is associated with higher levels of type-2 inflammation and symptom burden Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma Year: 2021
Regarding the role of F ENO in predicting failure after ICS reduction in mild-to-moderate asthma patients Source: Eur Respir J, 56 (2) 2002375; 10.1183/13993003.02375-2020 Year: 2020
Specific comorbidities and low adherence are independent risk factors for poorer asthma control and exacerbations in patients with difficult-to-control asthma Source: International Congress 2019 – Long-term evaluation and control of airway diseases Year: 2019
Are a degree of asthma therapy related to asthma control impairment? Source: Eur Respir J 2003; 22: Suppl. 45, 370s Year: 2003
The role of IL-18 level and genetic polymorphism in patients with bronchial asthma and its relation to disease severity Source: Annual Congress 2012 - Gene-environment treatment and asthma Year: 2012
Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 335s Year: 2001
Are there sub groups of children with asthma where FeNO guided treatment is associated with reduced risk for asthma attacks? Source: International Congress 2017 – Diagnostic tools in paediatric asthma Year: 2017
Prediction of the risk of future exacerbations in patients with severe persistent allergic asthma Source: Annual Congress 2005 - Severe asthma: perception and management Year: 2005
Relationship between asthma control and quality of life in different levels of asthma severity Source: Annual Congress 2010 - Clinical aspects of asthma and allergic respiratory diseases Year: 2010
Role of neutrophils in maintenance of severity of non-allergic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 585s Year: 2007
The effects of rhinitis and smoking on evaluating the asthma control with asthma control test (ACT), FEV1 and FeNO Source: Annual Congress 2008 - Understanding airway inflammation Year: 2008
The relationship between asthma symptom control scores and rhinosinusitis scores in difficult-to-treat asthma Source: Annual Congress 2008 - Understanding airway inflammation Year: 2008
The assesment of serum TNFα levels in COPD acute exacerbation and the effects of inhaler steroids on clinical and inflammatory determinants Source: Eur Respir J 2002; 20: Suppl. 38, 312s Year: 2002
The correlation between asthma severity and rhinitis severity Source: Eur Respir J 2002; 20: Suppl. 38, 45s Year: 2002